Zhenhai Zhang Selected Research

baohuoside I

11/2017	Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.
1/2017	Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
1/2016	d-α-Tocopheryl polyethylene glycol succinate/Solutol HS 15 mixed micelles for the delivery of baohuoside I against non-small-cell lung cancer: optimization and in vitro, in vivo evaluation.
1/2016	TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer.
7/2012	Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenhai Zhang Research Topics

Disease

33	Neoplasms (Cancer) 02/2022 - 02/2009
9	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2016
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017 - 07/2012
6	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 04/2017
5	Ulcerative Colitis 09/2022 - 02/2021
5	Adenocarcinoma 08/2022 - 01/2017
5	Infections 01/2022 - 04/2013
4	Inflammation (Inflammations) 08/2022 - 09/2014
4	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2012
3	Carcinoma (Carcinomatosis) 10/2018 - 01/2013
2	Edema (Dropsy) 08/2022 - 01/2020
2	Hypercholesterolemia 01/2021 - 01/2019
2	Proteinuria 11/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 11/2019 - 04/2017
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2016 - 09/2014
2	Aneurysm (Aneurysms) 03/2015 - 01/2014
1	Colitis 08/2022
1	Skin Diseases (Skin Disease) 07/2022
1	Atopic Dermatitis (Atopic Eczema) 07/2022
1	Overactive Urinary Bladder (Overactive Bladder) 04/2022
1	Breakthrough Infections 01/2022
1	Body Weight (Weight, Body) 12/2021
1	Heart Failure 09/2021
1	Myocardial Infarction 09/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2021
1	Cerebral Infarction 09/2021
1	Wounds and Injuries (Trauma) 08/2021
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2021
1	Cholestasis 01/2021

Drug/Important Bio-Agent (IBA)

13	MicellesIBA 07/2022 - 12/2013
8	Paclitaxel (Taxol)FDA LinkGeneric 08/2022 - 12/2012
8	Pharmaceutical PreparationsIBA 07/2022 - 12/2012
8	Liposomes (Liposome)IBA 01/2020 - 09/2011
6	Therapeutic UsesIBA 08/2022 - 11/2019
6	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2013
5	Hyaluronic Acid (Hyaluronan)IBA 07/2022 - 12/2012
5	tocophersolanIBA 02/2022 - 12/2013
5	baohuoside IIBA 11/2017 - 07/2012
4	Gemcitabine FDA Link 08/2022 - 01/2017
4	Succinic Acid (Succinate)IBA 01/2021 - 01/2016
4	parthenolideIBA 06/2020 - 01/2018
4	AntibodiesIBA 01/2020 - 05/2014
3	HydrogelsIBA 08/2022 - 11/2020
3	ChitosanIBA 12/2021 - 11/2020
3	Betulinic AcidIBA 01/2020 - 02/2019
3	Biological ProductsIBA 12/2019 - 01/2017
3	LigandsIBA 11/2019 - 01/2017
3	CholesterolIBA 01/2019 - 08/2009
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2017 - 01/2016
3	Cell-Penetrating PeptidesIBA 01/2015 - 12/2012
2	Simvastatin (Zocor)FDA LinkGeneric 08/2022 - 01/2017
2	honokiolIBA 08/2022 - 01/2020
2	Cholic AcidIBA 02/2022 - 05/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	VaccinesIBA 01/2022 - 04/2015
2	Neutralizing AntibodiesIBA 01/2022 - 05/2014
2	Immunoglobulin G (IgG)IBA 01/2022 - 12/2021
2	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 04/2015
2	jugloneIBA 08/2021 - 12/2016
2	ProdrugsIBA 05/2021 - 01/2021
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 05/2021 - 12/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 11/2019
2	Nanoparticle Drug Delivery SystemIBA 11/2020 - 01/2016
2	FlavonoidsIBA 10/2019 - 01/2016
2	ginsenoside M1IBA 01/2018 - 09/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 07/2012
2	ErbB Receptors (EGF Receptor)IBA 04/2017 - 01/2014
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2016 - 01/2016
2	celastrolIBA 01/2013 - 09/2011
1	polygalacturonic acid (pectic acid)IBA 09/2022
1	Prostaglandins AIBA 09/2022
1	hydroxypropylcellulose (hydroxypropyl cellulose)FDA Link 08/2022
1	Secretory Immunoglobulin A (SIgA)IBA 08/2022
1	PrebioticsIBA 08/2022
1	paeonolIBA 07/2022
1	CyclodextrinsIBA 07/2022
1	oxybutynin (Tavor)FDA LinkGeneric 04/2022
1	Volatile Fatty AcidsIBA 04/2022
1	CY5.5 cyanine dyeIBA 02/2022
1	monomethoxypolyethylene glycol (MPEG)IBA 02/2022
1	bufalinIBA 02/2022
1	NanovaccinesIBA 01/2022
1	CytokinesIBA 12/2021
1	SaponinsIBA 09/2021
1	Polysaccharides (Glycans)IBA 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AmidesIBA 01/2021
1	AnthracyclinesIBA 01/2021
1	DiureticsIBA 01/2021
1	Circular RNAIBA 01/2021
1	Proprotein Convertase 9IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	polyethylene glycol 2000IBA 01/2021

Therapy/Procedure

11	Therapeutics 08/2022 - 09/2010
3	Oral Administration 09/2022 - 12/2013
2	Intravenous Injections 09/2022 - 01/2016
2	Injections 11/2020 - 01/2017
1	Skin Care 07/2022
1	Immunotherapy 01/2021